CA2319117A1 - Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes - Google Patents

Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes Download PDF

Info

Publication number
CA2319117A1
CA2319117A1 CA002319117A CA2319117A CA2319117A1 CA 2319117 A1 CA2319117 A1 CA 2319117A1 CA 002319117 A CA002319117 A CA 002319117A CA 2319117 A CA2319117 A CA 2319117A CA 2319117 A1 CA2319117 A1 CA 2319117A1
Authority
CA
Canada
Prior art keywords
leu
ser
glu
ala
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002319117A
Other languages
English (en)
Inventor
Steven G. Reed
Michael J. Lodes
Tony N. Frudakis
Raodoh Mohamath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2319117A1 publication Critical patent/CA2319117A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des composés et méthodes de traitement du cancer du poumon. Les composés de l'invention comprennent des polypeptides contenant au moins une portion d'une protéine de tumeur pulmonaire. L'invention concerne encore des vaccins et compositions pharmaceutiques destinés à l'immunothérapie du cancer du poumon et comprenant de tels polypeptides, ou des polynucléotides codants ces polypeptides, ainsi que des polynucléotides servant à la préparation des polypeptides de l'invention.
CA002319117A 1998-01-28 1999-01-26 Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes Abandoned CA2319117A1 (fr)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US1502998A 1998-01-28 1998-01-28
US1502298A 1998-01-28 1998-01-28
US09/015,022 1998-01-28
US09/015,029 1998-01-28
US4083198A 1998-03-18 1998-03-18
US4082898A 1998-03-18 1998-03-18
US09/040,831 1998-03-18
US09/040,828 1998-03-18
US12219298A 1998-07-23 1998-07-23
US12219198A 1998-07-23 1998-07-23
US09/122,192 1998-07-23
US09/122,191 1998-07-23
US21924598A 1998-12-22 1998-12-22
US09/219,245 1998-12-22
PCT/US1999/001642 WO1999038973A2 (fr) 1998-01-28 1999-01-26 Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes

Publications (1)

Publication Number Publication Date
CA2319117A1 true CA2319117A1 (fr) 1999-08-05

Family

ID=27567530

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002319117A Abandoned CA2319117A1 (fr) 1998-01-28 1999-01-26 Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes

Country Status (13)

Country Link
EP (1) EP1051489A2 (fr)
JP (1) JP2002516659A (fr)
KR (1) KR20010034436A (fr)
CN (1) CN1292029A (fr)
AR (1) AR014514A1 (fr)
AU (1) AU2344399A (fr)
BR (1) BR9907259A (fr)
CA (1) CA2319117A1 (fr)
ID (1) ID27813A (fr)
IL (1) IL137417A0 (fr)
NO (1) NO20003853L (fr)
WO (1) WO1999038973A2 (fr)
ZA (1) ZA99693B (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
EP1526383A3 (fr) * 1998-08-31 2005-11-16 Pfizer Products Inc. Protéines de liaison pour diarylsulfonylurée
EP0987552A3 (fr) 1998-08-31 2000-06-07 Pfizer Products Inc. Protéines de liaison pour diarylsulfonylurée
WO2000026241A2 (fr) * 1998-10-28 2000-05-11 Rigel Pharmaceuticals, Inc. Nouvelles compositions et nouveaux procedes pour identifier par criblage des modulateurs d'activation des lymphocytes t et des lymphocytes b
EP1140137A2 (fr) * 1998-12-18 2001-10-10 Scios Inc. Methodes de detection et d'utilisation de genes exprimes de fa on differentielle dans des maladies
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000046370A1 (fr) * 1999-02-04 2000-08-10 Board Of Trustees Of The University Of Illinois Compositions p37ing1 et procedes d'utilisation
AU772103B2 (en) 1999-02-19 2004-04-08 Zymogenetics Inc. Inhibitors for use in hemostasis and immune function
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
US6444425B1 (en) 1999-04-02 2002-09-03 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
JP2002540790A (ja) * 1999-04-02 2002-12-03 コリクサ コーポレイション 肺癌の治療および診断のための化合物ならびにその使用のための方法
CZ20013527A3 (cs) * 1999-04-02 2002-10-16 Corixa Corporation Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030125245A1 (en) 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6914132B1 (en) 1999-06-30 2005-07-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6746846B1 (en) 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
US6686447B1 (en) 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6858204B2 (en) 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
JP2004500029A (ja) 1999-06-30 2004-01-08 コリクサ　コーポレイション 肺癌の治療および診断のための組成物および方法
CA2309313A1 (fr) * 1999-08-05 2001-02-05 Board Of Trustees Of The University Of Arkansas Stimulation de la reponse immunitaire par manipulation des cellules dendritiques humaines
AU7832700A (en) * 1999-09-23 2001-04-24 Corixa Corporation Ovarian tumor antigen and methods of use therefor
CA2490909A1 (fr) * 1999-12-01 2001-06-07 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
WO2001079282A2 (fr) * 2000-04-14 2001-10-25 Incyte Genomics, Inc. Molecules associees a la reproduction humaine
US20020099012A1 (en) * 2000-06-29 2002-07-25 Tongtong Wang Compositions and methods for the therapy and diagnosis of lung cancer
JP2004512824A (ja) * 2000-07-11 2004-04-30 コリクサ　コーポレイション 肺癌の治療および診断のための組成物および方法
WO2002006455A2 (fr) * 2000-07-19 2002-01-24 Bayer Aktiengesellschaft Regulation de l'enzyme de type trypsine protease humaine des voies respiratoires
TWI317380B (en) * 2000-08-28 2009-11-21 Teijin Ltd Airway-specific trypsin-like enzymes and method of using the same
JP2005530479A (ja) 2001-01-16 2005-10-13 セローノ ジェネティクス インスティテュート ソシエテ アノニム 代謝遺伝子ポリヌクレオチドおよびポリペプチド並びにそれらの使用
US7226994B2 (en) 2001-01-18 2007-06-05 Cambridge University Technical Services Limited Cell surface expressed marker of pluripotency
GB0101300D0 (en) * 2001-01-18 2001-02-28 Univ Cambridge Tech Primordial germ cell genes
JP2005505258A (ja) 2001-06-21 2005-02-24 イシス・イノベイション・リミテッド アトピーにおけるａｎｇｅ遺伝子
US20040081653A1 (en) * 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
AU2007216892B2 (en) * 2002-08-16 2011-02-10 Agensys, Inc. Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
AU2003296330A1 (en) * 2002-12-10 2004-06-30 Epimmune Inc. Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
WO2006060653A2 (fr) * 2004-11-30 2006-06-08 Veridex Llc Pronostics de cancer du poumon
EP1951281B1 (fr) 2005-10-17 2015-04-15 Sloan Kettering Institute For Cancer Research Peptides de liaison wt1 hla de classe ii, compositions et methodes associees comprenant ces peptides
EP3117836A1 (fr) 2006-04-10 2017-01-18 Sloan Kettering Institute For Cancer Research Peptides wt-1 immunogènes et leurs utilisations
EP2423332A1 (fr) * 2006-08-25 2012-02-29 Oncotherapy Science, Inc. Marqueurs de pronostic et cibles thérapeutiques pour le cancer des poumons
EP2334826A4 (fr) * 2008-09-12 2012-01-25 Cancer Res Initiative Foundation Procédé de détection et diagnostic de cancers buccaux et rhino-pharyngiens
CN101891802B (zh) * 2009-08-11 2011-11-16 武汉凯泰新生物技术有限公司 治疗或预防癌症的多肽或衍生产品及其应用
CN101921313B (zh) * 2010-04-07 2012-02-29 武汉凯泰新生物技术有限公司 治疗或预防癌症的多肽或其衍生产品及应用
GB201104286D0 (en) * 2011-03-15 2011-04-27 Randox Lab Ltd Glutathione S-transferase omega 1 wild type specific antibody
US9644026B2 (en) * 2011-09-09 2017-05-09 Trans Genic Inc. Antibody against mutant α-actinin-4
CN104684577B (zh) 2012-01-13 2018-05-08 纪念斯隆凯特林癌症中心 免疫原性wt-1肽及其使用方法
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
PT2945647T (pt) 2013-01-15 2020-11-26 Memorial Sloan Kettering Cancer Center Péptidos imunogénicos wt-1 e métodos de uso dos mesmos
EP3440101B1 (fr) * 2016-04-04 2021-10-06 Indi Molecular, Inc. Agents de capture spécifiques de cd8, compositions et procédés d'utilisation et de production
CN110139927B (zh) * 2016-11-16 2024-06-07 加利福尼亚大学董事会 Crispr-cas9抑制剂
CN110669104B (zh) * 2019-10-30 2021-11-05 上海交通大学 一组来源于人外周血单核细胞的标志物及其应用
CN112500467B (zh) * 2020-12-14 2022-05-24 上海交通大学 一种生物活性肽rrecpsdecgagvf及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
ID27813A (id) 2001-04-26
BR9907259A (pt) 2002-01-22
IL137417A0 (en) 2001-07-24
AR014514A1 (es) 2001-02-28
ZA99693B (en) 1999-10-21
AU2344399A (en) 1999-08-16
JP2002516659A (ja) 2002-06-11
KR20010034436A (ko) 2001-04-25
WO1999038973A3 (fr) 1999-12-09
CN1292029A (zh) 2001-04-18
NO20003853L (no) 2000-09-27
WO1999038973A2 (fr) 1999-08-05
NO20003853D0 (no) 2000-07-27
EP1051489A2 (fr) 2000-11-15

Similar Documents

Publication Publication Date Title
CA2319117A1 (fr) Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes
US6444425B1 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
EP1064372B1 (fr) Composes et methodes therapeutiques et diagnostiques du cancer du poumon
KR101204241B1 (ko) 혈액암의 검출, 진단 및 치료를 위한 조성물 및 방법
EP1992640A1 (fr) Composés pour l'immunothérapie et le diagnostic du cancer du sein et leurs procédés d'utilisation
CZ20023567A3 (cs) Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic
US20040175744A1 (en) Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers
JP2002533082A (ja) 結腸癌の免疫療法および診断のための化合物およびそれらの使用のための方法
US6410507B1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US6387697B1 (en) Compositions for treatment and diagnosis of breast cancer and methods for their use
US20020048759A1 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
US20020111467A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
AU4213000A (en) Compositions and methods for the treatment and diagnosis of breast cancer
JP2004527240A (ja) 癌細胞の増殖を調節するのに有用なポリヌクレオチド
US20010018058A1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US6379951B1 (en) Compounds for immunotherapy of breast cancer and methods for their use
US6284241B1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US20030194764A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
JP2009195236A (ja) 乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
US20030059781A1 (en) Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
EP1792988A2 (fr) Composés et méthodes thérapeutiques et diagnostiques du cancer du poumon
CA2370482A1 (fr) Compositions et procedes utilises en therapie et dans le diagnostic de l'epithelioma malpighien spinocellulaire de la tete et du cou

Legal Events

Date Code Title Description
FZDE Discontinued